Your browser doesn't support javascript.
loading
COVID-19 in donation and transplant.
Candel, F J; Pardo Rey, C; Torres-González, J I; Fernández-Vega, P; Fragiel, M; Oteo, D; Del Toro, E; Vega-Bayol, M; Outon, C; Encabo, M; García-Marugán, A; Resino, S; Parra, D; Matesanz, M; Del Rio Gallegos, F J.
Afiliación
  • Candel FJ; Francisco J Candel, Clinical Microbiology and Infectious Diseases. Transplant Coordination and Cell Tissue Bank. IdISSC Health Research Institute. Hospital Clinico San Carlos. Associate Professor. School of Medicine. Complutense University. Madrid. Spain. franciscojavier.candel@salud.madrid.org.
Rev Esp Quimioter ; 35 Suppl 3: 54-62, 2022 Oct.
Article en En | MEDLINE | ID: mdl-36285860
ABSTRACT
SARS-CoV-2 infection has had a major impact on donation and transplantation. Since the cessation of activity two years ago, the international medical community has rapidly generated evidence capable of sustaining and increasing this neccesary activity. This paper analyses the epidemiology and burden of COVID-19 in donation and transplantation, the pathogenesis of the infection and its relationship with graft-mediated transmission, the impact of vaccination on donation and transplantation, the evolution of donation in Spain throughout the pandemic, some lessons learned in SARS-CoV-2 infected donor recipients with positive PCR and the applicability of the main therapeutic tools recently approved for treatment among transplant recipients.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Órganos / COVID-19 Límite: Humans Idioma: En Revista: Rev Esp Quimioter Asunto de la revista: TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Órganos / COVID-19 Límite: Humans Idioma: En Revista: Rev Esp Quimioter Asunto de la revista: TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article